Title | Name | Pay | Currency Pay | Gender | Year Born | Title Since |
---|---|---|---|---|---|---|
Chief Scientific Officer | Dr. Iain A. Stuart Ph.D. | 577426 | USD | 1973 | N/A | |
Senior Vice President of Intellectual Property | Mr. David Schuz | N/A | USD | male | 1954 | N/A |
Chief Financial Officer, Principal Accounting Officer & Treasurer | Mr. Tyler Zeronda | N/A | USD | male | 1986 | 1679737032 |
Consultant | Dr. Darrell S. Rigel M.S., M.D., MS | N/A | USD | 1950 | N/A | |
Gen. Counsel, Chief Legal Officer & Company Sec. | Ms. Mutya Harsch J.D. | 577910 | USD | female | 1975 | N/A |
Senior Vice President of Pharmaceutical Devel. | Dr. Russell Elliott D.Phil. | N/A | USD | 1966 | N/A | |
Chief Financial Officer & Treasurer | Mr. Tyler Zeronda | N/A | USD | male | 1986 | N/A |
Chief Executive Officer, Pres & Director | Mr. David T. Domzalski | 974916 | USD | male | 1967 | N/A |
Symbol | Date | Rating | Rating Score | Rating Details |
---|---|---|---|---|
VYNE | 2 June, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 1 June, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 31 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 30 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 26 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 25 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 24 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 23 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 22 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 19 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 18 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 17 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 16 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 15 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 12 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 11 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 10 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 9 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 8 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 5 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 4 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 3 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 2 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 1 May, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 28 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 27 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 26 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 25 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 24 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 21 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 20 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 19 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 18 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 17 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 14 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 13 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 12 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 10 April, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 31 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 30 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 29 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 28 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 27 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 24 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 23 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 21 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 20 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 17 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 15 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 14 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 13 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 10 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 9 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 8 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 7 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 6 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 3 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 2 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 1 March, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 28 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 27 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 24 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 23 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 22 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 21 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 17 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 16 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 13 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 10 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 9 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 8 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 6 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 3 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 2 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 1 February, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 31 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 30 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 27 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 26 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 25 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 24 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 23 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 20 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 18 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 17 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 13 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 12 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 11 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 10 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 9 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 6 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 5 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 4 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 3 January, 2023 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 30 December, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 29 December, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 28 December, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 27 December, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 23 December, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
VYNE | 22 December, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Sell) Rating DCF: (Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Neutral) |
Holder | Shares | Date Reported | Change |
---|---|---|---|
STALEY CAPITAL ADVISERS INC | 3473 | 31 December, 2022 | 0 |
RUSSELL INVESTMENTS GROUP, LTD. | 188 | 31 December, 2022 | 3375 |
CSS LLC/IL | 1341 | 31 December, 2022 | 0 |
TWO SIGMA SECURITIES, LLC | 1051 | 31 December, 2022 | 1051 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 916 | 31 December, 2022 | -469 |
CITADEL ADVISORS LLC | 2998 | 31 December, 2022 | -1814 |
NORTHERN TRUST CORP | 4971 | 31 December, 2022 | 4 |
BANK OF NEW YORK MELLON CORP | 1480 | 31 December, 2022 | 58 |
MARINER, LLC | 695 | 31 December, 2022 | -81 |
BEACON POINTE ADVISORS, LLC | 4112 | 31 December, 2022 | -55 |
MACKENZIE FINANCIAL CORP | 7496 | 31 December, 2022 | 0 |
DSC ADVISORS, L.P. | 87223 | 31 December, 2022 | -61111 |
MORGAN STANLEY | 1298 | 31 December, 2022 | -16 |
MILLENNIUM MANAGEMENT LLC | 27112 | 31 December, 2022 | 16072 |
TOBIAS FINANCIAL ADVISORS, INC. | 612 | 31 December, 2022 | 612 |
FIRST MANHATTAN CO | 143 | 31 December, 2022 | 143 |
STATE STREET CORP | 11670 | 31 December, 2022 | 0 |
FEDERATED HERMES, INC. | 128 | 31 December, 2022 | 0 |
TOWER RESEARCH CAPITAL LLC (TRC) | 1434 | 31 December, 2022 | -1471 |
TEKLA CAPITAL MANAGEMENT LLC | 7522 | 31 December, 2022 | 0 |
BLACKROCK INC. | 49213 | 31 December, 2022 | -14 |
LPL FINANCIAL LLC | 940 | 31 December, 2022 | -400 |
UBS GROUP AG | 3038 | 31 December, 2022 | 44217 |
GEODE CAPITAL MANAGEMENT, LLC | 24950 | 31 December, 2022 | -62 |
DELTEC ASSET MANAGEMENT LLC | 1667 | 31 December, 2022 | 0 |
RENAISSANCE TECHNOLOGIES LLC | 48158 | 31 December, 2022 | -3454 |
VANGUARD GROUP INC | 91701 | 31 December, 2022 | 1118 |
THRIVENT FINANCIAL FOR LUTHERANS | 3060 | 31 December, 2022 | 0 |
BANK OF AMERICA CORP /DE/ | 4934 | 31 December, 2022 | 130 |
INVESTORS RESEARCH CORP | 9 | 31 December, 2022 | 150 |
FRANKLIN RESOURCES INC | 5341 | 31 December, 2022 | 0 |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 49 | 31 December, 2022 | 49 |
CETERA ADVISOR NETWORKS LLC | 6389 | 31 December, 2022 | 0 |
JANE STREET GROUP, LLC | 1027 | 31 December, 2022 | -1786 |
WELLS FARGO & COMPANY/MN | 87 | 31 December, 2022 | 87 |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 36 | 31 December, 2022 | 36 |
TEKLA CAPITAL MANAGEMENT LLC | 7522 | 30 September, 2022 | 0 |
CSS LLC/IL | 1341 | 30 September, 2022 | -63 |
VIRTU FINANCIAL LLC | 3415 | 30 September, 2022 | -188 |
Symbol | Transaction Date | Reporting Cik | Securities Owned | Company Cik | Reporting Name | Acquistion Or Disposition | Form Type | Securities Transacted | Security Name | Link |
---|---|---|---|---|---|---|---|---|---|---|
VYNE | 31 May, 2023 | 0001727809 | 25907 | 0001566044 | Harsch Mutya | A | 4 | 3664 | Common Stock | View |
VYNE | 31 May, 2023 | 0001727794 | 53414 | 0001566044 | Domzalski David | A | 4 | 2766 | Common Stock | View |
VYNE | 31 March, 2023 | 0001867033 | 8108 | 0001566044 | Zeronda Tyler | D | 4 | 384 | Common Stock | View |
VYNE | 31 March, 2023 | 0001727756 | 10390 | 0001566044 | Stuart Iain | D | 4 | 480 | Common Stock | View |
VYNE | 31 March, 2023 | 0001727809 | 22243 | 0001566044 | Harsch Mutya | D | 4 | 478 | Common Stock | View |
VYNE | 31 March, 2023 | 0001727794 | 50648 | 0001566044 | Domzalski David | D | 4 | 2734 | Common Stock | View |
VYNE | 31 December, 2022 | 0001727809 | 229144 | 0001566044 | Harsch Mutya | D | 4 | 1813 | Common Stock | View |
VYNE | 31 December, 2022 | 0001727756 | 220252 | 0001566044 | Stuart Iain | D | 4 | 1720 | Common Stock | View |
VYNE | 31 December, 2022 | 0001867033 | 173005 | 0001566044 | Zeronda Tyler | D | 4 | 354 | Common Stock | View |
VYNE | 31 December, 2022 | 0001727794 | 1064290 | 0001566044 | Domzalski David | D | 4 | 10685 | Common Stock | View |
VYNE | 30 November, 2022 | 0001727794 | 1074975 | 0001566044 | Domzalski David | A | 4 | 34705 | Common Stock | View |
VYNE | 30 September, 2022 | 0001867033 | 173359 | 0001566044 | Zeronda Tyler | D | 4 | 353 | Common Stock | View |
VYNE | 30 September, 2022 | 0001727756 | 221972 | 0001566044 | Stuart Iain | D | 4 | 1719 | Common Stock | View |
VYNE | 30 September, 2022 | 0001727809 | 230957 | 0001566044 | Harsch Mutya | D | 4 | 1813 | Common Stock | View |
VYNE | 30 September, 2022 | 0001727794 | 1040270 | 0001566044 | Domzalski David | D | 4 | 10683 | Common Stock | View |
VYNE | 10 August, 2022 | 0001632295 | 20500 | 0001566044 | Sandoval Elisabeth | A | 4 | 20500 | Stock Options | View |
VYNE | 10 August, 2022 | 0001055404 | 20500 | 0001566044 | LEPORE PATRICK G | A | 4 | 20500 | Stock Options | View |
VYNE | 10 August, 2022 | 0001374180 | 20500 | 0001566044 | Bruno Anthony D | A | 4 | 20500 | Stock Options | View |
VYNE | 10 August, 2022 | 0001417397 | 20500 | 0001566044 | Basta Steven L | A | 4 | 20500 | Stock Options | View |
VYNE | 10 August, 2022 | 0001240499 | 20500 | 0001566044 | BARBARI SHARON | A | 4 | 20500 | Stock Options | View |
VYNE | 30 June, 2022 | 0001867033 | 173712 | 0001566044 | Zeronda Tyler | D | 4 | 354 | Common Stock | View |
VYNE | 30 June, 2022 | 0001727756 | 223691 | 0001566044 | Stuart Iain | D | 4 | 1719 | Common Stock | View |
VYNE | 30 June, 2022 | 0001727809 | 232770 | 0001566044 | Harsch Mutya | D | 4 | 1813 | Common Stock | View |
VYNE | 30 June, 2022 | 0001727794 | 1050953 | 0001566044 | Domzalski David | D | 4 | 10683 | Common Stock | View |
VYNE | 31 May, 2022 | 0001867033 | 174066 | 0001566044 | Zeronda Tyler | A | 4 | 12510 | Common Stock | View |
VYNE | 31 May, 2022 | 0001727794 | 1061636 | 0001566044 | Domzalski David | A | 4 | 11887 | Common Stock | View |
VYNE | 31 March, 2022 | 0001867033 | 161556 | 0001566044 | Zeronda Tyler | D | 4 | 773 | Common Stock | View |
VYNE | 31 March, 2022 | 0001727756 | 225410 | 0001566044 | Stuart Iain | D | 4 | 3469 | Common Stock | View |
VYNE | 31 March, 2022 | 0001727809 | 234583 | 0001566044 | Harsch Mutya | D | 4 | 3630 | Common Stock | View |
VYNE | 31 March, 2022 | 0001727794 | 1049749 | 0001566044 | Domzalski David | D | 4 | 23186 | Common Stock | View |
VYNE | 17 March, 2022 | 0001867033 | 75000 | 0001566044 | Zeronda Tyler | A | 4 | 75000 | Stock Options | View |
VYNE | 17 March, 2022 | 0001727756 | 75000 | 0001566044 | Stuart Iain | A | 4 | 75000 | Stock Options | View |
VYNE | 17 March, 2022 | 0001727809 | 75000 | 0001566044 | Harsch Mutya | A | 4 | 75000 | Stock Options | View |
VYNE | 17 March, 2022 | 0001727794 | 1072935 | 0001566044 | Domzalski David | A | 4 | 312302 | Common Stock | View |
VYNE | 31 December, 2021 | 0001867033 | 87329 | 0001566044 | Zeronda Tyler | D | 4 | 206 | Common Stock | View |
VYNE | 31 December, 2021 | 0001727756 | 153879 | 0001566044 | Stuart Iain | D | 4 | 1250 | Common Stock | View |
VYNE | 31 December, 2021 | 0001727809 | 163213 | 0001566044 | Harsch Mutya | D | 4 | 1484 | Common Stock | View |
VYNE | 31 December, 2021 | 0001727794 | 760633 | 0001566044 | Domzalski David | D | 4 | 6887 | Common Stock | View |
VYNE | 30 November, 2021 | 0001867033 | 87535 | 0001566044 | Zeronda Tyler | A | 4 | 4187 | Common Stock | View |
VYNE | 30 November, 2021 | 0001055404 | 62500 | 0001566044 | LEPORE PATRICK G | A | 4 | 12500 | Common Stock | View |
VYNE | 30 November, 2021 | 0001727794 | 767520 | 0001566044 | Domzalski David | A | 4 | 4705 | Common Stock | View |
VYNE | 30 September, 2021 | 0001867033 | 83348 | 0001566044 | Zeronda Tyler | D | 4 | 206 | Common Stock | View |
VYNE | 30 September, 2021 | 0001727756 | 155129 | 0001566044 | Stuart Iain | D | 4 | 1480 | Common Stock | View |
VYNE | 30 September, 2021 | 0001727809 | 164697 | 0001566044 | Harsch Mutya | D | 4 | 1484 | Common Stock | View |
VYNE | 30 September, 2021 | 0001727794 | 762815 | 0001566044 | Domzalski David | D | 4 | 13096 | Common Stock | View |
VYNE | 2 September, 2021 | 0001867033 | 83554 | 0001566044 | Zeronda Tyler | A | 4 | 60859 | Common Stock | View |
VYNE | 2 September, 2021 | 0001867033 | 60860 | 0001566044 | Zeronda Tyler | A | 4 | 60860 | Stock Options | View |
VYNE | 2 September, 2021 | 0001727756 | 156609 | 0001566044 | Stuart Iain | A | 4 | 60859 | Common Stock | View |
VYNE | 2 September, 2021 | 0001727756 | 60860 | 0001566044 | Stuart Iain | A | 4 | 60860 | Stock Options | View |
VYNE | 2 September, 2021 | 0001727809 | 166181 | 0001566044 | Harsch Mutya | A | 4 | 60859 | Common Stock | View |
VYNE | 2 September, 2021 | 0001727809 | 60860 | 0001566044 | Harsch Mutya | A | 4 | 60860 | Stock Options | View |
VYNE | 2 September, 2021 | 0001727794 | 775911 | 0001566044 | Domzalski David | A | 4 | 320312 | Common Stock | View |
VYNE | 2 September, 2021 | 0001727794 | 320313 | 0001566044 | Domzalski David | A | 4 | 320313 | Stock Options | View |
VYNE | 25 August, 2021 | 0001055404 | 50000 | 0001566044 | LEPORE PATRICK G | A | 4 | 12500 | Common Stock | View |
VYNE | 16 August, 2021 | 0001224962 | 4935057 | 0001566044 | PERCEPTIVE ADVISORS LLC | D | 4 | 250000 | Common Stock | View |
VYNE | 13 August, 2021 | 0001224962 | 5185057 | 0001566044 | PERCEPTIVE ADVISORS LLC | D | 4 | 250000 | Common Stock | View |
VYNE | 12 August, 2021 | 0001224962 | 5435057 | 0001566044 | PERCEPTIVE ADVISORS LLC | D | 4 | 338897 | Common Stock | View |
VYNE | 19 July, 2021 | 0001632295 | 20500 | 0001566044 | Sandoval Elisabeth | A | 4 | 20500 | Stock Options | View |
VYNE | 19 July, 2021 | 0001055404 | 20500 | 0001566044 | LEPORE PATRICK G | A | 4 | 20500 | Stock Options | View |
VYNE | 19 July, 2021 | 0001374180 | 20500 | 0001566044 | Bruno Anthony D | A | 4 | 20500 | Stock Options | View |
VYNE | 19 July, 2021 | 0001327501 | 20500 | 0001566044 | Bright Rex | A | 4 | 20500 | Stock Options | View |
VYNE | 19 July, 2021 | 0001417397 | 20500 | 0001566044 | Basta Steven L | A | 4 | 20500 | Stock Options | View |
VYNE | 19 July, 2021 | 0001240499 | 20500 | 0001566044 | BARBARI SHARON | A | 4 | 20500 | Stock Options | View |
VYNE | 30 June, 2021 | 0001867033 | 22695 | 0001566044 | Zeronda Tyler | D | 4 | 700 | Common Stock | View |
VYNE | 30 June, 2021 | 0001759703 | 109246 | 0001566044 | Wiley Matthew T. | D | 4 | 5151 | Common Stock | View |
VYNE | 30 June, 2021 | 0001727756 | 95750 | 0001566044 | Stuart Iain | D | 4 | 3083 | Common Stock | View |
VYNE | 30 June, 2021 | 0001727809 | 105322 | 0001566044 | Harsch Mutya | D | 4 | 3551 | Common Stock | View |
VYNE | 30 June, 2021 | 0001727794 | 455599 | 0001566044 | Domzalski David | D | 4 | 18859 | Common Stock | View |
VYNE | 18 June, 2021 | 0001867033 | 23395 | 0001566044 | Zeronda Tyler | D | 3 | 0 | Common Stock | View |
VYNE | 18 June, 2021 | 0001867033 | 0 | 0001566044 | Zeronda Tyler | D | 3 | 13504 | Stock Option | View |
VYNE | 18 June, 2021 | 0001867033 | 0 | 0001566044 | Zeronda Tyler | D | 3 | 4375 | Stock Option | View |
VYNE | 18 June, 2021 | 0001867033 | 0 | 0001566044 | Zeronda Tyler | D | 3 | 9375 | Stock Option | View |
VYNE | 18 June, 2021 | 0001867033 | 0 | 0001566044 | Zeronda Tyler | D | 3 | 18834 | Stock Option | View |
VYNE | 28 May, 2021 | 0001616284 | 116468 | 0001566044 | Saik Andrew | A | 4 | 3017 | Common Stock | View |
VYNE | 28 May, 2021 | 0001727794 | 474458 | 0001566044 | Domzalski David | A | 4 | 941 | Common Stock | View |
VYNE | 26 May, 2021 | 0001055404 | 37500 | 0001566044 | LEPORE PATRICK G | A | 4 | 12500 | Common Stock | View |
VYNE | 6 May, 2021 | 0001224962 | 5773954 | 0001566044 | PERCEPTIVE ADVISORS LLC | D | 4 | 1000000 | Common Stock | View |
VYNE | 31 March, 2021 | 0001759703 | 114397 | 0001566044 | Wiley Matthew T. | D | 4 | 2573 | Common Stock | View |
VYNE | 31 March, 2021 | 0001727756 | 98833 | 0001566044 | Stuart Iain | D | 4 | 1945 | Common Stock | View |
VYNE | 31 March, 2021 | 0001616284 | 113451 | 0001566044 | Saik Andrew | D | 4 | 762 | Common Stock | View |
VYNE | 31 March, 2021 | 0001727809 | 108873 | 0001566044 | Harsch Mutya | D | 4 | 1765 | Common Stock | View |
VYNE | 31 March, 2021 | 0001727794 | 473517 | 0001566044 | Domzalski David | D | 4 | 6316 | Common Stock | View |
VYNE | 15 March, 2021 | 0001055404 | 25000 | 0001566044 | LEPORE PATRICK G | A | 4 | 12500 | Common Stock | View |
VYNE | 22 February, 2021 | 0001759703 | 116970 | 0001566044 | Wiley Matthew T. | A | 4 | 27675 | Common Stock | View |
VYNE | 22 February, 2021 | 0001759703 | 64575 | 0001566044 | Wiley Matthew T. | A | 4 | 64575 | Stock Options | View |
VYNE | 22 February, 2021 | 0001727756 | 100778 | 0001566044 | Stuart Iain | A | 4 | 29213 | Common Stock | View |
VYNE | 22 February, 2021 | 0001727756 | 68162 | 0001566044 | Stuart Iain | A | 4 | 68162 | Stock Options | View |
VYNE | 22 February, 2021 | 0001616284 | 114213 | 0001566044 | Saik Andrew | A | 4 | 29213 | Common Stock | View |
VYNE | 22 February, 2021 | 0001616284 | 68162 | 0001566044 | Saik Andrew | A | 4 | 68162 | Stock Options | View |
VYNE | 22 February, 2021 | 0001727809 | 110638 | 0001566044 | Harsch Mutya | A | 4 | 29213 | Common Stock | View |
VYNE | 22 February, 2021 | 0001727809 | 68162 | 0001566044 | Harsch Mutya | A | 4 | 68162 | Stock Options | View |
VYNE | 22 February, 2021 | 0001727794 | 479833 | 0001566044 | Domzalski David | A | 4 | 153750 | Common Stock | View |
VYNE | 22 February, 2021 | 0001727794 | 358750 | 0001566044 | Domzalski David | A | 4 | 358750 | Stock Options | View |
VYNE | 28 January, 2021 | 0001224962 | 27095819 | 0001566044 | PERCEPTIVE ADVISORS LLC | A | 4 | 4219409 | Common Stock | View |
VYNE | 31 December, 2020 | 0001759703 | 357181 | 0001566044 | Wiley Matthew T. | D | 4 | 1541 | Common Stock | View |
VYNE | 31 December, 2020 | 0001727756 | 286262 | 0001566044 | Stuart Iain | D | 4 | 2378 | Common Stock | View |
VYNE | 31 December, 2020 | 0001727809 | 325703 | 0001566044 | Harsch Mutya | D | 4 | 1822 | Common Stock | View |
VYNE | 31 December, 2020 | 0001727794 | 1304334 | 0001566044 | Domzalski David | D | 4 | 9656 | Common Stock | View |
VYNE | 3 December, 2020 | 0001055404 | 50000 | 0001566044 | LEPORE PATRICK G | A | 4 | 50000 | Common Stock | View |
VYNE | 30 November, 2020 | 0001759703 | 358722 | 0001566044 | Wiley Matthew T. | A | 4 | 7838 | Common Stock | View |
Symbol | Date | Period | Download XLSX File |
---|---|---|---|
VYNE | 2022 | FY | Download XLSX File |
VYNE | 2021 | FY | Download XLSX File |
VYNE | 2020 | FY | Download XLSX File |
VYNE | 2019 | FY | Download XLSX File |
VYNE | 2018 | FY | Download XLSX File |
VYNE | 2017 | FY | Download XLSX File |
VYNE | 2022 | Q1 | Download XLSX File |
VYNE | 2022 | Q3 | Download XLSX File |
VYNE | 2022 | Q4 | Download XLSX File |
VYNE | 2022 | Q2 | Download XLSX File |
VYNE | 2021 | Q3 | Download XLSX File |
VYNE | 2021 | Q1 | Download XLSX File |
VYNE | 2021 | Q2 | Download XLSX File |
VYNE | 2021 | Q4 | Download XLSX File |
VYNE | 2020 | Q3 | Download XLSX File |
VYNE | 2020 | Q4 | Download XLSX File |
VYNE | 2020 | Q1 | Download XLSX File |
VYNE | 2020 | Q2 | Download XLSX File |
VYNE | 2019 | Q3 | Download XLSX File |
VYNE | 2019 | Q4 | Download XLSX File |
VYNE | 2019 | Q1 | Download XLSX File |
VYNE | 2019 | Q2 | Download XLSX File |
VYNE | 2018 | Q2 | Download XLSX File |
VYNE | 2018 | Q4 | Download XLSX File |
VYNE | 2018 | Q3 | Download XLSX File |
VYNE | 2018 | Q1 | Download XLSX File |
VYNE | 2017 | Q4 | Download XLSX File |
Chart
|
|
Financials Yearly
Financials Quarterly
Upgrades & Downgrades
Company Historical Earnings
Date | Symbol | EPS | EPS Estimated | Time | Revenue | Revenue Estimated |
---|---|---|---|---|---|---|
9 May, 2024 | VYNE | bmo | ||||
7 March, 2024 | VYNE | bmo | ||||
8 November, 2023 | VYNE | bmo | ||||
10 August, 2023 | VYNE | bmo | 100000 | |||
11 May, 2023 | VYNE | -1.74 | -1.74 | bmo | 99000 | |
9 March, 2023 | VYNE | -3.33 | -3.33 | bmo | 60000 | |
10 November, 2022 | VYNE | -2.88 | -2.88 | bmo | 167000 | |
12 August, 2022 | VYNE | -2.34 | -2.34 | bmo | 126000 | |
12 May, 2022 | VYNE | -2.52 | -2.52 | bmo | 178000 | |
17 March, 2022 | VYNE | -3.6 | -3.6 | bmo | 2292000 | 4120000 |
10 November, 2021 | VYNE | -6.48 | -6.48 | bmo | 4086000 | 3095454 |
12 August, 2021 | VYNE | -6.3 | -6.3 | bmo | 4258000 | 7530000 |
6 May, 2021 | VYNE | -6.66 | -6.66 | bmo | 4119000 | 4520853 |
4 March, 2021 | VYNE | -9.9 | -9.9 | bmo | 4286000 | |
5 November, 2020 | VYNE | -10.8 | -10.8 | bmo | 3269000 | 14049933.333333 |
6 August, 2020 | VYNE | -14.4 | -14.4 | bmo | 11688000 | 22137500 |
11 May, 2020 | VYNE | -68.4 | -68.4 | bmo | 1750000 | 1564059.375 |
3 March, 2020 | VYNE | -64.08 | -64.08 | bmo | 11561247.191011 | |
31 October, 2019 | VYNE | -50.4 | -50.4 | bmo | 13636700 | |
1 August, 2019 | VYNE | -49.68 | -49.68 | bmo | 15092000 | |
2 May, 2019 | VYNE | -58.32 | -58.32 | bmo | 12397000 | |
27 February, 2019 | VYNE | -54.72 | -54.72 | bmo | 13212592.105263 | |
7 November, 2018 | VYNE | -40.32 | -40.32 | bmo | 19702375 | |
1 August, 2018 | VYNE | -25.92 | -25.92 | bmo | 10143000 | 27204527.777778 |
9 May, 2018 | VYNE | -51.84 | -51.84 | bmo | 497000 | 11363916.666667 |
28 March, 2018 | VYNE | -129.6 | -129.6 | bmo | 2775000 | 4752183.3333333 |
30 September, 2017 | VYNE | -50.98991 | -50.98991 | bmo | 909000 | |
30 June, 2017 | VYNE | -38.39218 | -38.39218 | bmo | 449000 | |
31 March, 2017 | VYNE | -34.1555 | -34.1555 | bmo | 449000 | |
31 December, 2016 | VYNE | -30.18089 | -30.18089 | bmo | 450000 |
Company Profile
CEO Mr. David T. Domzalski
Sector Healthcare
Industry Biotechnology
Website https://www.vynetherapeutics.com
Exchange NASDAQ Global Select
Description VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.